Miyako Igarashi

Miyako Igarashi

Auto-generated profile, based on publicly available information

Miyako Igarashi

Department of Cardiology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2016 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Open access
KMKeita Masuda
Keita Masuda
ANAkihiko Nogami
Akihiko Nogami
KKKenji Kuroki
Kenji Kuroki
MIMiyako Igarashi
Miyako Igarashi
YSYukio Sekiguchi
Yukio Sekiguchi
KAKazutaka Aonuma
Kazutaka Aonuma
Background—: Catheter ablation is an effective therapy for ventricular fibrillation (VF) arising from the Purkinje system in ischemic heart disease. However, some patients experience newly emergent monomorphic ventricular tachycardia (VT) after the ablation of VF. We evaluated the prevalence and mechanism of monomorphic VT after VF ablation. Methods and Results—: Twenty-one consecutive patients with primary VF because of ischemic heart disease who underwent catheter ablation were retrospectively analyzed. Twenty of 21 patients were in electrical storm. Ventricular premature contractions triggering VF arose from the left Purkinje system and were targeted for ablation. Before the ablation, 14 of 21 patients had only VF, and the other 7 had VF and concomitant monomorphic VT. Four of the 14 patients with only VF (29%) exhibited newly emergent monomorphic VT after VF ablation. Three of these patients had Purkinje-related VTs, which were successfully eliminated by the ablation of a Purkinje network located in the same low-voltage area as the site of prior successful VF ablation. During a median follow-up of 28 months (interquartile range, 16–68 months), VF recurred in 6 of 21 patients (29%); however, there were neither electrical storms nor monomorphic VT, and all recurring arrhythmias were controlled by medical therapy alone. Conclusions—: Over one fifth of patients with primary ischemic VF experienced newly emergent Purkinje-related monomorphic VT after VF ablation. The circuit of the monomorphic VT associated with the Purkinje network was located in the same low-voltage area as the Purkinje tissue that triggered VF and could be suppressed by additional ablation.

24 February 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TMTakeshi Machino
Takeshi Machino
KAKazutaka Aonuma
Kazutaka Aonuma
KMKazushi Maruo
Kazushi Maruo
YKYuki Komatsu
Yuki Komatsu
HYHiro Yamasaki
Hiro Yamasaki
MIMasaki Ieda
Masaki Ieda
Background: Atrial fibrillation (AF) is the most common arrhythmia and often recurs despite catheter ablation. The recurrence of AF is often underdiagnosed by standard 24-hour electrocardiogram (ECG) because of its transient and silent nature. A garment-style ECG with a highly conductive textile electrode made of poly(3,4-ethylenedioxythiophene) poly(styrenesulfonate)(PEDOTPSS) and nanofiber (Garment ECG) has been developed that can provide longer-term continuous monitoring. This study investigated whether 2-week Garment ECG can reveal instances of AF recurrence in patients who are diagnosed as remaining in sinus rhythm by 24-hour Holter ECG.Methods: The open-label randomized crossover study enrolled 67 patients (63.1±10.6 years old, 53 men) who had undergone initial AF ablation. Three months after ablation, patients were randomly assigned to group 1 (n = 35), 2-week Garment ECG followed by 24-hour Holter ECG, or group 2 (n = 32), 24-hour Holter ECG followed by 2-week Garment ECG. The detection of AF recurrence was compared between the two devices.Results: The Garment ECG showed AF recurrence in 12 patients (18%) compared to 4 patients for the Holter ECG (6%, p = 0.008). The ECG acquisition rate was higher for Holter ECG than for Garment ECG (100.0% [interquartile range 100.0–100.0%] versus 82.4% [71.1–91.0%], p<0.001), but the Garment ECG provided longer total analysis time (11.0 days [9.0–12.2 days] for Garment; 1.0 day [1.0–1.0 day] for Holter, p<0.001).Conclusions: Despite the lower ECG acquisition rate, the 2-week Garment ECG revealed instances of AF recurrence after ablation in patients who were underdiagnosed by 24-hour Holter ECG.Trial registration: Clinical Trial Registration:URL:https://jrct.niph.go.jp/en-latest-detail/jRCTs032180018Unique Identifier:jRCTs032180018.

1 March 2020 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
PDF file
YSYasutoshi Shinoda
Yasutoshi Shinoda
YKYuki Komatsu
Yuki Komatsu
ANAkihiko Nogami
Akihiko Nogami
MIMiyako Igarashi
Miyako Igarashi
HYHiro Yamasaki
Hiro Yamasaki
MIMasaki Ieda
Masaki Ieda

1 September 2020 in International Heart Journal
Verified
Journal Article
Closed access
PDF file
KOKojiro Ogawa
Kojiro Ogawa
MIMiyako Igarashi
Miyako Igarashi
ANAkihiko Nogami
Akihiko Nogami
MYMasayoshi Yamamoto
Masayoshi Yamamoto
ASAkinori Sugano
Akinori Sugano
MIMasaki Ieda
Masaki Ieda
Identifying the optimal atrioventricular (AV) or interventricular (VV) delay is beneficial for patients using cardiac resynchronization therapy (CRT) devices. Ultrasonic echocardiography (UCG) has been the most commonly used method; however, it requires high technical knowledge. Impedance cardiography (ICG) can calculate stroke volume by measuring changes in transthoracic electric impedance. This study sought to assess the clinical utility of ICG in comparison with that of UCG for the optimization of CRT devices. Patients who underwent CRT device implantation were retrospectively analyzed. One week after implantation, optimization of AV delay (AVD) was performed in every patient with ICG (AVD-ICG) and UCG (AVD-UCG). VV delay (VVD) was then determined according to the optimal AVD using these two methods. Forty-two patients were enrolled. Average AVD-ICG was significantly shorter than AVD-UCG (128 +/- 49 versus 146 +/- 41 milliseconds, P = 0.018). Five patients (12%) had the same optimized AVD with two methods, and the difference between AVD-ICG and AVD-UCG was <= 20 milliseconds in 19 patients (45%). In the multivariate analysis, the presence of postoperative mitral regurgitation (MR) was an independent predictor of AVD-ICG/AVD-UCG mismatch, defined as a difference over 20 milliseconds (odds ratio = 10.71; 95% confidence interval = 1.72 to 66.72; P = 0.018). The results of optimized VVD were similar using both methods. ICG might be a promising tool for the rapid optimization of CRT devices. However, in patients with moderate-to-severe MR. ICG may not be able to optimize AVD.

1 June 2021 in CJC Open
Verified
Journal Article
Open access
COChihiro Ota
Chihiro Ota
MIMiyako Igarashi
Miyako Igarashi
ANAkihiko Nogami
Akihiko Nogami
TITomoko Ishizu
Tomoko Ishizu
KAKazutaka Aonuma
Kazutaka Aonuma
MIMasaki Ieda
Masaki Ieda
Radiofrequency catheter ablation (RFCA) is the primary choice for treating patients with an accessory pathway and atrioventricular re-entrant tachycardia. However, using RFCA to treat a right-sided accessory pathway in a patient with Ebstein anomaly can be difficult owing to challenges in locating the electrophysiological atrioventricular groove. We report a case of atrioventricular re-entrant tachycardia in a patient with Ebstein anomaly and a right-sided accessory pathway that was successfully treated using RFCA and 3-dimensional (3D) high-density mapping. RFCA and 3D mapping may be useful in the management of such cases and may aid in improving prognoses of patients.

10 December 2024 in International Journal of Cardiology Congenital Heart Disease
Verified
Journal Article
Open access
QNQasim J. Naeemah
Qasim J. Naeemah
MIMiyako Igarashi
Miyako Igarashi
NANoor K. Albakaa
Noor K. Albakaa
YHYuichi Hanaki
Yuichi Hanaki
NINoboru Ichihara
Noboru Ichihara
TITomoko Ishizu
Tomoko Ishizu
Patients with repaired tetralogy of Fallot (TOF) now live longer. However, dysrhythmia becomes prevalent in adults with repaired TOF, especially atrial tachyarrhythmia. To identify the characteristics of patients who develop atrial tachycardia (AT) and the mechanism of the clinical AT and the induced one. Seventy-seven patients with repaired TOF were enrolled. The patients were divided into two groups (AT and non-AT). Clinical and electrophysiologic data were studied. The mean age was 34 years. Twenty-three patients had AT (30 %). In AT group, the left ventricular ejection fraction was lower (58 ± 6 vs 62 ± 5; P = 0.011), the right and left atrial area (cm2) was larger (29 ± 13 vs 15 ± 5; P < 0.001, and 19 ± 3 vs 16 ± 4; P < 0.001, respectively), and the right ventricular S' wave (cm/s) was smaller (8 ± 2 vs 10 ± 3; P = 0.029).Patients with AT underwent catheter ablation, and 32 AT were ablated. The mechanism of AT was intra-atrial reentrant tachycardia in 14 AT (44 %), cavotricuspid isthmus-dependent in 12 AT (37 %), and focal activity in the remaining 6 AT (19 %). An important finding was that after the first AT was ablated, another AT was induced in 7 patients. The mechanism was focal in about half of them, in contrast to the first ablated AT, where the focal mechanism was the least common. After a median follow-up of 37 months, four patients had AT recurrence. The patients with AT had biventricular dysfunction and bi-atrial dilatation. Aggressive induction and ablation of the induced AT may reduce the future AT recurrence.